日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemia

毛细胞白血病患者严重感染和机会性感染的发生率、描述和时间

Kapoor, Nilesh; Zhao, Qiuhong; Stiff, Andrew; Bhat, Seema A; Anghelina, Mirela I; Andritsos, Leslie A; Blachly, James S; Epperla, Narendranath; Boghdadly, Zeinab El; Grever, Michael R; Rogers, Kerry A

Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2

单中心研究:毛细胞白血病患者感染SARS-CoV-2后的预后

Annunzio, Kaitlin; Ozga, Michael; Huang, Ying; Anghelina, Mirela; Bhat, Seema A; Blachly, James S; Grever, Michael R; Lozanski, Gerard; Neal, Jasmine; Shindiapina, Polina; Rogers, Kerry A

Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy

维莫非尼单药治疗复发或难治性毛细胞白血病患者的长期疗效

Handa, Shivani; Lee, Jeong-Ok; Derkach, Andriy; Stone, Richard M; Saven, Alan; Altman, Jessica K; Grever, Michael R; Rai, Kanti R; Shukla, Madhulika; Vemuri, Shreya; Montoya, Skye; Taylor, Justin; Abdel-Wahab, Omar; Tallman, Martin S; Park, Jae H

Phase 2 study of ibrutinib in classic and variant hairy cell leukemia

伊布替尼治疗经典型和变异型毛细胞白血病的 II 期研究

Rogers, Kerry A; Andritsos, Leslie A; Wei, Lai; McLaughlin, Eric M; Ruppert, Amy S; Anghelina, Mirela; Blachly, James S; Call, Timothy; Chihara, Dai; Dauki, Anees; Guo, Ling; Ivy, S Percy; James, Lacey R; Jones, Daniel; Kreitman, Robert J; Lozanski, Gerard; Lucas, David M; Ngankeu, Apollinaire; Phelps, Mitch; Ravandi, Farhad; Schiffer, Charles A; Carson, William E; Jones, Jeffrey A; Grever, Michael R

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia

慢性淋巴细胞白血病诊断时,伴有突变IGHV和细胞遗传学复杂性的易位预后意义

Heerema, Nyla A; Muthusamy, Natarajan; Zhao, Qiuhong; Ruppert, Amy S; Breidenbach, Heather; Andritsos, Leslie A; Grever, Michael R; Maddocks, Kami J; Woyach, Jennifer; Awan, Farrukh; Long, Meixiao; Gordon, Amber; Coombes, Caitlin; Byrd, John C

A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome

一项评估来那度胺联合伊达比星和阿糖胞苷化疗治疗复发或难治性急性髓系白血病和高危骨髓增生异常综合征患者的I期研究

Saygin, Caner; Larkin, Karilyn; Blachly, James S; Orwick, Shelley; Ngankeu, Apollinaire; Gregory, Charles T; Phelps, Mitch A; Mani, Shylaja; Walker, Alison; Garzon, Ramiro; Vasu, Sumithira; Walsh, Katherine J; Bhatnagar, Bhavana; Klisovic, Rebecca B; Grever, Michael R; Marcucci, Guido; Byrd, John C; Blum, William; Mims, Alice S

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study

维利帕尼联合卡铂间歇和持续给药方案治疗转移性乳腺癌的I期研究:安全性和[18F]-氟胸苷正电子发射断层扫描生物标志物研究

Wesolowski, Robert; Stover, Daniel G; Lustberg, Maryam B; Shoben, Abigail; Zhao, Meng; Mrozek, Ewa; Layman, Rachel M; Macrae, Erin; Duan, Wenrui; Zhang, Jun; Hall, Nathan; Wright, Chadwick L; Gillespie, Susan; Berger, Michael; Chalmers, Jeffrey J; Carey, Alahdra; Balasubramanian, Priya; Miller, Brandon L; Amaya, Peter; Andreopoulou, Eleni; Sparano, Joseph; Shapiro, Charles L; Villalona-Calero, Miguel Angel; Geyer, Susan; Chen, Alice; Grever, Michael R; Knopp, Michael V; Ramaswamy, Bhuvaneswari

Clara D. Bloomfield, M.D. (1942-2020): Legacy in Leukemia Research

克拉拉·D·布卢姆菲尔德医学博士(1942-2020):白血病研究领域的杰出贡献

Grever, Michael R

A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485

一种针对复发/难治性成人急性髓系白血病的新型治疗方案,采用KMT2A部分串联重复靶向疗法:NCI 8485 1期研究结果

Mims, Alice S; Mishra, Anjali; Orwick, Shelley; Blachly, James; Klisovic, Rebecca B; Garzon, Ramiro; Walker, Alison R; Devine, Steven M; Walsh, Katherine J; Vasu, Sumithira; Whitman, Susan; Marcucci, Guido; Jones, Daniel; Heerema, Nyla A; Lozanski, Gerard; Caligiuri, Michael A; Bloomfield, Clara D; Byrd, John C; Piekarz, Richard; Grever, Michael R; Blum, William

Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia

曲美替尼用于治疗IGHV4-34、MAP2K1突变型毛细胞白血病

Andritsos, Leslie A; Grieselhuber, Nicole R; Anghelina, Mirela; Rogers, Kerry A; Roychowdhury, Sameek; Reeser, Julie W; Timmers, Cynthia D; Freud, Aharon G; Blachly, James S; Lucas, David M; Lozanski, Gerard; Jones, Jeffrey A; Williams, Katie; Oakes, Christopher; Jones, Dan; Grever, Michael R